Clinical Trial

Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 18, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
An effective therapy of persistent atrial fibrillation beyond pulmonary vein isolation remains unsatisfactory. Targeting endocardial low-voltage areas represents an approach of substrate modification. This prospective, randomized study investigated the efficacy of ablation of low-voltage areas versus PVI and additional linear ablations in patients with persistent atrial fibrillation in terms of single-procedure arrhythmia-free outcome and safety.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-11-03.
Trial Details
NCT Number NCT06124690
Lead Sponsor Robert Bosch Medical Center
Conditions Persistent Atrial Fibrillation, Catheter Ablation, Low Voltage Areas
Enrollment 150 participants
Start Date 2023-09-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-12-18